AnGes MG, Inc. - Product Pipeline Review - 2013

AnGes MG, Inc. - Product Pipeline Review - 2013

$1,500.00

Publication ID
GMD1213135
Publication Date
December 31, 2013
Pages
43
Regions Covered
Publisher

AnGes MG, Inc. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “AnGes MG, Inc. - Product Pipeline Review - 2013” provides data on the AnGes MG, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, AnGes MG, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from AnGes MG, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- AnGes MG, Inc. - Brief AnGes MG, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of AnGes MG, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of AnGes MG, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the AnGes MG, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate AnGes MG, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of AnGes MG, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the AnGes MG, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with AnGes MG, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of AnGes MG, Inc. and identify potential opportunities in those areas.

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
AnGes MG, Inc. Snapshot 5
AnGes MG, Inc. Overview 5
Key Information 5
Key Facts 5
AnGes MG, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
AnGes MG, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Partnered Products 11
Partnered Products/Combination Treatment Modalities 12
AnGes MG, Inc. - Pipeline Products Glance 13
AnGes MG, Inc. - Late Stage Pipeline Products 13
Filing rejected/Withdrawn Products/Combination Treatment Modalities 13
Phase III Products/Combination Treatment Modalities 14
AnGes MG, Inc. - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
AnGes MG, Inc. - Early Stage Pipeline Products 17
IND/CTA Filed Products/Combination Treatment Modalities 17
Preclinical Products/Combination Treatment Modalities 18
AnGes MG, Inc. - Drug Profiles 19
beperminogene perplasmid 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
velimogene aliplasmid 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
S-414114 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
GEN-0101 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Cervical Intraepithelial Neoplasia Therapeutic Vaccine 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
AnGes MG, Inc. - Pipeline Analysis 29
AnGes MG, Inc. - Pipeline Products by Therapeutic Class 29
AnGes MG, Inc. - Pipeline Products by Target 31
AnGes MG, Inc. - Pipeline Products by Route of Administration 33
AnGes MG, Inc. - Pipeline Products by Molecule Type 34
AnGes MG, Inc. - Pipeline Products by Mechanism of Action 35
AnGes MG, Inc. - Recent Pipeline Updates 36
AnGes MG, Inc. - Dormant Projects 39
AnGes MG, Inc. - Company Statement 40
AnGes MG, Inc. - Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Appendix 42
Methodology 42
Coverage 42
Secondary Research 42
Primary Research 42
Expert Panel Validation 42
Contact Us 43
Disclaimer 43

List of Tables
AnGes MG, Inc., Key Information 5
AnGes MG, Inc., Key Facts 5
AnGes MG, Inc. - Pipeline by Indication, 2013 8
AnGes MG, Inc. - Pipeline by Stage of Development, 2013 9
AnGes MG, Inc. - Monotherapy Products in Pipeline, 2013 10
AnGes MG, Inc. - Partnered Products in Pipeline, 2013 11
AnGes MG, Inc. - Partnered Products/ Combination Treatment Modalities, 2013 12
AnGes MG, Inc. - Filing rejected/Withdrawn, 2013 13
AnGes MG, Inc. - Phase III, 2013 14
AnGes MG, Inc. - Phase II, 2013 15
AnGes MG, Inc. - Phase I, 2013 16
AnGes MG, Inc. - IND/CTA Filed, 2013 17
AnGes MG, Inc. - Preclinical, 2013 18
AnGes MG, Inc. - Pipeline by Therapeutic Class, 2013 30
AnGes MG, Inc. - Pipeline by Target, 2013 32
AnGes MG, Inc. - Pipeline by Route of Administration, 2013 33
AnGes MG, Inc. - Pipeline by Molecule Type, 2013 34
AnGes MG, Inc. - Pipeline Products by Mechanism of Action, 2013 35
AnGes MG, Inc. - Recent Pipeline Updates, 2013 36
AnGes MG, Inc. - Dormant Developmental Projects,2013 39
AnGes MG, Inc., Other Locations 41
AnGes MG, Inc., Subsidiaries 41

List of Figures
AnGes MG, Inc. - Pipeline by Top 10 Indication, 2013 7
AnGes MG, Inc. - Pipeline by Stage of Development, 2013 9
AnGes MG, Inc. - Monotherapy Products in Pipeline, 2013 10
AnGes MG, Inc. - Partnered Products in Pipeline, 2013 11
AnGes MG, Inc. - Pipeline by Top 10 Therapeutic Class, 2013 29
AnGes MG, Inc. - Pipeline by Top 10 Target, 2013 31
AnGes MG, Inc. - Pipeline by Top 10 Route of Administration, 2013 33
AnGes MG, Inc. - Pipeline by Top 10 Molecule Type, 2013 34
AnGes MG, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2013 35

NA
How to buy market research report?
 

Process to buy a market research report from us

Step 1: Select publication license from Publication Type dropdown.
Step 2: Click Add To Cart button.
Step 3: The report is added to your cart and you are redirected to cart page.
Step 4: Enter Coupon Code (if applicable) and click on Apply to order button.
Step 5: Review your cart and either click on Checkout button to proceed or click on Checkout with PayPal button for Express Checkout. Please note PayPal option is not available for buyers from India.
Step 6: Enter your E-mail Address and choose your desired Username and Password for a new account or login with your existing account.
Step 7: Enter your Billing Information.
Step 8: Choose your Payment Method from either 2Checkout (default option) or PayPal and click on Review order button.
Step 9: Review your order and click on Submit order button to go to payment gateway and make payments.
Step 10: You can change your language and currency if you have selected 2Checkout as your payment option. Your billing information is pre-filled, so you can proceed to Payment Method tab.
Step 11: Enter your Credit/Debit Card details and click Submit Payment button to make payment and complete purchase process.
 
Please contact us if you need an Invoice or any other information regarding purchase process.

Do you have more questions related to this market research report after going trhough the description and table of contents?

We are here to help. Please use the form given below to let us know your questions related to this report.

Kindly use your official email address and contact number to ensure speedy response.

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

SINGLE USER LICENSE (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Global License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

SITE USER LICENSE (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Global License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

GLOBAL USER LICENSE (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Note: Product cover images are only for representative purpose only and may vary from those shown above.

Shopping cart

0 Items $0.00
Market Research Special Offers
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Related Market Research Reports

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data